Valeria Giuliani Scuola Normale Superiore Servizio alla Didattica e Allievi tel. 050 509260 Piazza dei Cavalieri, 7 56126 Pisa E-mail: valeria.giuliani@sns.it E-mail: classi@sns.it
---------- Forwarded message --------- Da: Classi SNS classi@sns.it Date: mer 12 giu 2019 alle ore 12:30 Subject: Avviso Colloquio della Classe di Scienze, Prof. Giulio Caracciolo (26 giugno 19) To: allievi.extra.sci allievi.extra.sci@sns.it, allievi.sci < allievi.sci@sns.it>, Assegnisti Scienze assegnisti.sci@sns.it, Borsisti < borsisti@sns.it>, Esterni Scienze in Convenzione < esterni_sci_inconvenzione@sns.it>, phd. sci phd.sci@sns.it, phd.extra.sci phd.extra.sci@sns.it, Professori Scienze professori.sci@sns.it, professori. emeriti professori.emeriti@sns.it, professori.contratto.sci < professori.contratto.sci@sns.it>, Ricercatori Scienze < ricercatori.sci@sns.it>, Ricercatori TD Scienze ricercatori.td.sci@sns.it, Visiting Students visiting.student@sns.it
Colloqui della Classe di Scienze - Anno Accademico 2018/2019
Mercoledì 26 giugno 2019
ore 15:00
Sala Stemmi Palazzo della Carovana
*Prof. Giulio Caracciolo*
(Department of Molecular Medicine, Sapienza University of Rome)
*Titolo*: “*Exploitation of nanoparticle–protein corona for emerging therapeutic and diagnostic applications”*
*Abstract:*
Despite the advances in biomedical applications of nanoparticles and numerous publications, few nanoparticles have made it to clinical trials and even fewer have reached clinical practice. This wide gap between bench discoveries and clinical applications is mainly because of our limited understanding of the biological identity of nanoparticles. In biological environments (e.g. blood, saliva, interstitial fluids etc.), nanoparticles are coated by a ‘protein corona’, critically affecting their synthetic identity and physiological response. In this talk, we highlight the emerging applications of protein corona towards its use in therapeutics and diagnostics. In particular, special emphasis is given to the exploitation of protein corona for targeted delivery of nanomaterials and early cancer detection. By highlighting such recent applications of protein corona, we hope to demonstrate that this bio-entity has the potential to determine the future success of nanoparticles in biomedicine beyond their currently envisioned purposes.
Giulio Caracciolo, Omid C. Farokhzad, Morteza Mahmoudi. Biological Identity of Nanoparticles In Vivo: Clinical Implications of the Protein Corona. Trends in Biotechnology, Volume 35, Issue 3, 1 March 2017, Pages 257-264.